Arrowhead Pharmaceuticals Refinances Credit Facility, Lowers Borrowing Costs

Arrowhead Pharmaceuticals completed a refinancing with funds managed by Sixth Street, lowering borrowing costs and extending its debt maturity. The transaction also improves near-term liquidity and increases financial and operational flexibility.